Globus Medical Shares Surge on Exceptional Quarterly Performance

The medical technology sector is witnessing a remarkable performance from Globus Medical, whose recent quarterly results have generated significant market enthusiasm. The company’s latest financial disclosures have not only surpassed expectations but have also triggered substantial revisions in analyst assessments.

During the third quarter of 2025, Globus Medical delivered financial results that dramatically outpaced market forecasts. Revenue climbed 22.9% to reach $769 million, with the recently integrated Nevro business contributing significantly to this expansion. Even more impressive was the adjusted earnings performance, with per-share profits surging 42.6% to $1.18, substantially above the $0.79 consensus estimate among market analysts.

Management has responded to this strong performance by raising full-year guidance. The company now anticipates 2025 revenue between Read more...